Davis Capital Management Acquires 5,109 Shares of Agilent Technologies, Inc. $A

Davis Capital Management boosted its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 2,365.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,325 shares of the medical research company’s stock after buying an additional 5,109 shares during the quarter. Davis Capital Management’s holdings in Agilent Technologies were worth $725,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Board of the Pension Protection Fund bought a new stake in shares of Agilent Technologies during the 4th quarter valued at approximately $27,000. Physician Wealth Advisors Inc. boosted its position in Agilent Technologies by 490.0% in the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after buying an additional 196 shares in the last quarter. State of Wyoming acquired a new stake in Agilent Technologies in the second quarter valued at approximately $35,000. SJS Investment Consulting Inc. grew its stake in shares of Agilent Technologies by 2,836.4% during the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after buying an additional 312 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in shares of Agilent Technologies during the third quarter worth $49,000.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Barclays dropped their price target on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. TD Cowen lowered their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and increased their target price for the company from $155.00 to $160.00 in a research report on Monday, January 5th. UBS Group cut their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $163.71.

View Our Latest Stock Report on A

Agilent Technologies Trading Down 5.8%

NYSE A opened at $113.48 on Thursday. The firm has a market capitalization of $32.07 billion, a PE ratio of 24.92, a price-to-earnings-growth ratio of 2.57 and a beta of 1.30. The business’s 50-day moving average price is $117.67 and its two-hundred day moving average price is $133.53. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 12 month low of $103.16 and a 12 month high of $160.27.

Agilent Technologies (NYSE:AGet Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.Agilent Technologies’s revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st were issued a $0.255 dividend. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s payout ratio is presently 22.52%.

About Agilent Technologies

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Further Reading

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.